Traders Buy Shares of UnitedHealth Group Inc. (UNH) on Weakness
Investors purchased shares of UnitedHealth Group Inc. (NYSE:UNH) on weakness during trading hours on Tuesday. $83.02 million flowed into the stock on the tick-up and $50.22 million flowed out of the stock on the tick-down, for a money net flow of $32.80 million into the stock. Of all companies tracked, UnitedHealth Group had the 17th highest net in-flow for the day. UnitedHealth Group traded down ($0.21) for the day and closed at $137.47
A number of research analysts have issued reports on UNH shares. Mizuho upped their price target on shares of UnitedHealth Group from $156.00 to $160.00 and gave the company a “buy” rating in a research note on Tuesday, July 19th. Credit Suisse Group AG restated a “buy” rating and set a $148.00 price target on shares of UnitedHealth Group in a research note on Wednesday, June 29th. Leerink Swann restated a “buy” rating on shares of UnitedHealth Group in a research note on Friday, June 10th. Citigroup Inc. upped their price target on shares of UnitedHealth Group from $148.00 to $164.00 and gave the company a “buy” rating in a research note on Wednesday, July 20th. Finally, Argus upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $170.00 price target on the stock in a research note on Friday, July 22nd. One equities research analyst has rated the stock with a hold rating, twenty-three have issued a buy rating and one has assigned a strong buy rating to the stock. UnitedHealth Group has an average rating of “Buy” and an average target price of $154.96.
The firm has a market cap of $130.93 billion, a PE ratio of 21.51 and a beta of 0.57. The firm has a 50-day moving average of $139.00 and a 200-day moving average of $135.11.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/21/traders-buy-shares-of-unitedhealth-group-inc-unh-on-weakness-2.html
UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, July 19th. The healthcare conglomerate reported $1.96 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.89 by $0.07. The company had revenue of $46.50 billion for the quarter, compared to analysts’ expectations of $45.05 billion. UnitedHealth Group had a net margin of 3.51% and a return on equity of 19.08%. On average, analysts anticipate that UnitedHealth Group Inc. will post $7.92 EPS for the current year.
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 20th. Shareholders of record on Friday, September 9th were paid a $0.625 dividend. The ex-dividend date was Tuesday, September 6th. This represents a $2.50 annualized dividend and a yield of 1.82%. UnitedHealth Group’s dividend payout ratio is currently 39.12%.
In other UnitedHealth Group news, Director Richard T. Burke sold 40,000 shares of the business’s stock in a transaction on Wednesday, September 7th. The shares were sold at an average price of $135.31, for a total value of $5,412,400.00. Following the transaction, the director now directly owns 2,003,550 shares of the company’s stock, valued at approximately $271,100,350.50. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 1.65% of the stock is currently owned by company insiders.
Institutional investors have recently made changes to their positions in the stock. Omega Advisors Inc. purchased a new position in shares of UnitedHealth Group during the first quarter valued at about $64,386,000. Edgar Lomax Co. VA boosted its position in shares of UnitedHealth Group by 0.7% in the first quarter. Edgar Lomax Co. VA now owns 503,143 shares of the healthcare conglomerate’s stock valued at $64,855,000 after buying an additional 3,438 shares in the last quarter. Gateway Investment Advisers LLC boosted its position in shares of UnitedHealth Group by 8.8% in the second quarter. Gateway Investment Advisers LLC now owns 815,807 shares of the healthcare conglomerate’s stock valued at $115,192,000 after buying an additional 66,274 shares in the last quarter. Origin Asset Management LLP purchased a new position in shares of UnitedHealth Group during the first quarter valued at about $34,616,000. Finally, Panagora Asset Management Inc. boosted its position in shares of UnitedHealth Group by 5.0% in the first quarter. Panagora Asset Management Inc. now owns 947,733 shares of the healthcare conglomerate’s stock valued at $122,163,000 after buying an additional 44,707 shares in the last quarter. 85.94% of the stock is currently owned by institutional investors.
About UnitedHealth Group
UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.